$0.26
arrow_drop_down5.73%Key Stats | |
---|---|
Open | $0.27 |
Prev. Close | $0.27 |
EPS | -14.43 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $2.86M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.25 | 0.27 |
52 Week Range | 0.25 | 14.22 |
Ratios | |
---|---|
Revenue | - |
EPS | -14.43 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 million
SciSparc Updates Regarding the Status of the AutoMax Merger
SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug
SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss - GlobeNewswire
Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Benzinga
SciSparc Secures Strategic Advantage with Grant of European Patent